HealthMerck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue
Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay is opening a new treatment avenue that doctors hope could work against many types of tumors.
Merck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue
